Skip to main content
FinSpry Logo
FinSpry
DXCM logo
DXCM
(NASDAQ)
DexCom, Inc.
$87.90-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

DexCom (DXCM) Stock Price & Financial Analysis

DexCom Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$87.65 - $89.00
52-Week High$92.59
52-Week Low$54.11
Open$88.78
Volume2.27M
Average Volume (3M)4.80M
Market Cap34.29B
Shares Outstanding390.10M
P/E Ratio (TTM)34.30
Forward P/E19.98
Price to Sales (P/S)6.90
Price to Book (P/B)13.08
EV/EBITDA22.11
Revenue (TTM)4.97B
Net Income (TTM)999.70M
Free Cash Flow (TTM)1.41B
EPS (TTM)$2.52
Profit Margin20.12%
Operating Margin22.92%
Return on Equity (ROE)38.14%
Debt to Equity0.47
50-Day MA$81.22
200-Day MA$70.90
52-Week Change9.18%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About DexCom

What is the current stock price for DXCM?

As of the latest trading session, DXCM stock trades at $87.90. The 52-week range is $54.11–$92.59, with a day range of $87.65–$89.00.

What is the P/E ratio for DXCM?

DexCom's trailing P/E ratio is 34.3, meaning investors pay $34.3 for every $1 of annual earnings. The forward P/E is 20.0, reflecting analyst expectations for future earnings. DexCom operates in the Healthcare sector.

Does DXCM pay dividends?

DexCom does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for DXCM?

Based on 7 analysts, the consensus for DXCM is Buy.

What is the market cap of DXCM?

DexCom's market capitalization is $34.29B, classifying it as a large-cap company. DexCom operates in the Healthcare sector within the Medical Devices industry.